|
Volumn 34, Issue 2, 2001, Pages 279-287
|
Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma
|
Author keywords
Pleural mesothelioma; Prognostic factors; Treatment
|
Indexed keywords
CISPLATIN;
DOXORUBICIN;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
ARTICLE;
CANCER CELL;
CANCER CHEMOTHERAPY;
CANCER SURGERY;
CANCER SURVIVAL;
CELL TYPE;
CONTROLLED STUDY;
DISEASE SEVERITY;
FEMALE;
HISTOLOGY;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MALIGNANT NEOPLASTIC DISEASE;
MULTIMODALITY CANCER THERAPY;
PALLIATIVE THERAPY;
PLEURA MESOTHELIOMA;
PLEURECTOMY;
PRIORITY JOURNAL;
PROGNOSIS;
SURVIVAL RATE;
TISSUE SECTION;
TISSUE TYPES;
TREATMENT OUTCOME;
|
EID: 0034777549
PISSN: 01695002
EISSN: None
Source Type: Journal
DOI: 10.1016/S0169-5002(01)00257-4 Document Type: Article |
Times cited : (111)
|
References (36)
|